Hereditary Overexpression of Adenosine Deaminase in Erythrocytes: Evidence for a Cis-acting Mutation

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1993 Oct 1

PMID 8213817

Authors

E H Chen

A P Tartaglia

B S Mitchell

Affiliations

Soon will be listed here.

Abstract

Overexpression of adenosine deaminase (ADA) in red blood cells is inherited as an autosomal dominant trait and causes hemolytic anemia. The increased ADA activity in erythrocytes is due to an increase in steady-state levels of ADA mRNA of normal sequence. Increased ADA mRNA may be due to a cis-acting mutation which results in increased transcription or a loss of down-regulation during erythroid differentiation. Alternatively, it is possible that the mutation is in a trans-acting factor which interacts with normal ADA transcriptional elements to cause overexpression in red blood cells. To discriminate between a cis-acting and a trans-acting mutation, we took advantage of a highly polymorphic TAAA repeat located at the tail end of an Alu repeat approximately 1.1 kb upstream of the ADA gene. Using PCR to amplify this region, we identified five different alleles in 19 members of the family. All 11 affected individuals had an ADA allele with 12 TAAA repeats, whereas none of the 8 normal individuals did. We conclude that this disorder results from a cis-acting mutation in the vicinity of the ADA gene.

References

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Berry M, Grosveld F, Dillon N . A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobin. Nature. 1992; 358(6386):499-502. DOI: 10.1038/358499a0. View

Miwa S, Fujii H, Matsumoto N, Nakatsuji T, Oda S, Asano H . A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan. Am J Hematol. 1978; 5(2):107-15. DOI: 10.1002/ajh.2830050205. View

Perignon J, Hamet M, Buc H, CARTIER P, Derycke M . Biochemical study of a case of hemolytic anemia with increased (85 fold) red cell adenosine deaminase. Clin Chim Acta. 1982; 124(2):205-12. DOI: 10.1016/0009-8981(82)90388-6. View

Glader B, Backer K, DIAMOND L . Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia. N Engl J Med. 1983; 309(24):1486-90. DOI: 10.1056/NEJM198312153092404. View

Lathrop G, Lalouel J . Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet. 1984; 36(2):460-5. PMC: 1684427. View

Cowan M, Brady R, Widder K . Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A. 1986; 83(4):1089-91. PMC: 323016. DOI: 10.1073/pnas.83.4.1089. View

Chottiner E, Cloft H, Tartaglia A, Mitchell B . Elevated adenosine deaminase activity and hereditary hemolytic anemia. Evidence for abnormal translational control of protein synthesis. J Clin Invest. 1987; 79(3):1001-5. PMC: 424261. DOI: 10.1172/JCI112866. View

Kanno H, Fujii H, Tani K, Morisaki T, Takahashi K, Horiuchi N . Elevated erythrocyte adenosine deaminase activity in a patient with primary acquired sideroblastic anemia. Am J Hematol. 1988; 27(3):216-20. DOI: 10.1002/ajh.2830270313. View

10.

Lattier D, States J, HUTTON J, Wiginton D . Cell type-specific transcriptional regulation of the human adenosine deaminase gene. Nucleic Acids Res. 1989; 17(3):1061-76. PMC: 331722. DOI: 10.1093/nar/17.3.1061. View

11.

Martin D, Tsai S, Orkin S . Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature. 1989; 338(6214):435-8. DOI: 10.1038/338435a0. View

12.

Gumucio D, Rood K, Gray T, Riordan M, Sartor C, Collins F . Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol. 1988; 8(12):5310-22. PMC: 365633. DOI: 10.1128/mcb.8.12.5310-5322.1988. View

13.

Gribbin T, Chottiner E, Ginsburg D, Mitchell B . Identification of an Apa I polymorphism within the human adenosine deaminase (ADA) gene. Nucleic Acids Res. 1989; 17(9):3626. PMC: 317836. DOI: 10.1093/nar/17.9.3626. View

14.

Ruano G, Pagliaro E, Schwartz T, Lamy K, Messina D, Gaensslen R . Heat-soaked PCR: an efficient method for DNA amplification with applications to forensic analysis. Biotechniques. 1992; 13(2):266-74. View

15.

Chottiner E, Ginsburg D, Tartaglia A, Mitchell B . Erythrocyte adenosine deaminase overproduction in hereditary hemolytic anemia. Blood. 1989; 74(1):448-53. View

16.

van der Weyden M, Harrison C, Hallam L, McVeigh D, Gan T, Taaffe L . Elevated red cell adenosine deaminase and haemolysis in a patient with a myelodysplastic syndrome. Br J Haematol. 1989; 73(1):129-31. DOI: 10.1111/j.1365-2141.1989.tb00233.x. View

17.

Aronow B, Lattier D, Silbiger R, Dusing M, Hutton J, Jones G . Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev. 1989; 3(9):1384-400. DOI: 10.1101/gad.3.9.1384. View

18.

Economou E, Bergen A, Warren A, Antonarakis S . The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome. Proc Natl Acad Sci U S A. 1990; 87(8):2951-4. PMC: 53811. DOI: 10.1073/pnas.87.8.2951. View

19.

Chen Z, Harless M, Wright D, Kellems R . Identification and characterization of transcriptional arrest sites in exon 1 of the human adenosine deaminase gene. Mol Cell Biol. 1990; 10(9):4555-64. PMC: 361043. DOI: 10.1128/mcb.10.9.4555-4564.1990. View

20.

Chen Z, Innis J, Sun M, Wright D, Kellems R . Sequence requirements for transcriptional arrest in exon 1 of the human adenosine deaminase gene. Mol Cell Biol. 1991; 11(12):6248-56. PMC: 361813. DOI: 10.1128/mcb.11.12.6248-6256.1991. View